Drugs

News and Updates about the regulations in Drugs and Pharma

Everest Medicines Reports Promising Outcomes from Phase 1b/2a Study of Innovative BTK Inhibitor, EVER001 for Primary Membranous Nephropathy Treatment

Everest Medicines, a biopharmaceutical company committed to pioneering the discovery, development, production, and commercialization of novel therapies, has shared promising outcomes from their ongoing phase 1b/2a trial evaluating EVER001 for primary membranous nephropathy (pMN). A cutting-edge covalent reversible Bruton’s tyrosine […]

Everest Medicines Reports Promising Outcomes from Phase 1b/2a Study of Innovative BTK Inhibitor, EVER001 for Primary Membranous Nephropathy Treatment Read More »

Novavax Strikes Deal to Sell Czech Republic Production Plant to Novo Nordisk for $200 Million

Novavax, Inc., an international leader in protein-based vaccines utilizing its Matrix-M adjuvant, has declared that it has secured a definitive transaction to divest its Bohumil, Czech Republic production site to Novo Nordisk for $200 million. The deal encompasses the transfer

Novavax Strikes Deal to Sell Czech Republic Production Plant to Novo Nordisk for $200 Million Read More »

Ono Pharma Partners with Congruence for Innovative Small Molecule Correctors in Oncology

Ono Pharmaceutical Co., Ltd. has revealed a strategic partnership agreement with Congruence Therapeutics, a cutting-edge biotechnology company based in Montreal, Canada. This collaboration focuses on developing new small molecule correctors targeting multiple protein pathways in the field of oncology, utilizing

Ono Pharma Partners with Congruence for Innovative Small Molecule Correctors in Oncology Read More »

Health Canada Gives Nod to Astellas Pharma’s Veozah: A Groundbreaking Non-Hormonal Option for Menopausal VMS Treatment

Astellas Pharma Canada, Inc. has announced Health Canada’s approval of Veozah (fezolinetant film-coated tablets) as the pioneering non-hormonal solution designed to address moderate to severe vasomotor symptoms related to menopause. As women transition through menopause, a phase that may dominate

Health Canada Gives Nod to Astellas Pharma’s Veozah: A Groundbreaking Non-Hormonal Option for Menopausal VMS Treatment Read More »

DCO India Appeals to Karnataka Chief Minister for Revocation of State Drug Controller’s Suspension

The Drug Control Officers India Welfare Association (DCO India), representing both active and retired drug regulation officials nationwide, has called upon the Karnataka government to reassess the suspension of Dr. S Umesh, the state’s drug controller. This action followed reports

DCO India Appeals to Karnataka Chief Minister for Revocation of State Drug Controller’s Suspension Read More »

Pharmexcil Requests Member Input on Overcoming Export Challenges and Innovative Solutions

In a strategic move to boost India’s global pharmaceutical presence by tackling export-related challenges, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has extended an invitation to its members to point out obstacles and suggest inventive growth strategies. Underlining the

Pharmexcil Requests Member Input on Overcoming Export Challenges and Innovative Solutions Read More »

Delhi Court Urges Government to Consider Inclusion of Ichthyosis as a Disability under RPwD Act

The Delhi High Court has prompted the central authority to contemplate a submission from the Center for Ichthyosis Related Members Foundation, an organization devoted to supporting individuals with Ichthyosis or those connected to them. The plea seeks recognition of Ichthyosis

Delhi Court Urges Government to Consider Inclusion of Ichthyosis as a Disability under RPwD Act Read More »